PI
ATNM icon

PFG Investments’s Actinium Pharmaceuticals ATNM Stock Holding History

PFG Investments’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-18,250
Closed -$23K – 1023
2024
Q4 		$23K Buy
+18,250
New +$28.3K ﹤0.01% 1007

Other funds holding ATNM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Los Angeles Capital Management
Los Angeles Capital Management Los Angeles, California $25.4B AUM 38.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PFG Investments's ATNM Position: Q1 2025 in Review

PFG Investments sold out of Actinium Pharmaceuticals (ATNM) in Q1 2025, closing a stake of 18,250 shares — an estimated $23K sold.

PFG Investments first reported a position in ATNM in Q4 2024 and held it in 1 quarter. The position peaked at $23K in Q4 2024. 69 funds tracked by Wall St. Rank hold ATNM as of Q1 2025.

  • PFG Investments reported no remaining Actinium Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • PFG Investments sold 18,250 Actinium Pharmaceuticals shares in Q1 2025, an estimated $23K.
  • PFG Investments first reported a position in Actinium Pharmaceuticals in Q4 2024 and held it in 1 quarter.
  • PFG Investments's Actinium Pharmaceuticals position peaked at $23K in Q4 2024.
  • 69 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q1 2025.

Based on PFG Investments's 13F filing for Q1 2025, filed 22 Apr 2025.